Showing results (41-50 of 299) with videos related to
Sort By:
Pageof 30
Blood|May 16, 2002
A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivoAnja Ehrhardt, Mark A KayMolecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2025
The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapyFrancesco Puzzo, Mark A KayEMBO Reports|September 19, 2012
Everybody wins! Poland hosts thrilling competitions of viruses, RNAi and football teamsDirk Grimm, Tamas Dalmay, Ronald P van RijMethods in Molecular Biology (Clifton, N.J.)|May 21, 2021
A Versatile In Vivo System to Study Myc in Cell ReprogrammingElena Senís, Lluc Mosteiro, Dirk Grimm, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2009
Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult miceShelly Beer, David I Bellovin, Joyce S Lee, et al.Blood|June 7, 2003
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapyDirk Grimm, Shangzhen Zhou, Hiroyuki Nakai, et al.Human Gene Therapy|January 12, 2017
Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and BeyondPaul N Valdmanis, Mark A KayMolecular and Cellular Biology|November 13, 2003
Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cellsStephen R Yant, Mark A KayJournal of Virology|June 14, 2003
Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivoAnja Ehrhardt, Hui Xu, Mark A KayPageof 30